Glaxo gets orders for H1N1 vaccine

GlaxoSmithKline said Friday several European governments had ordered stockpiles of a pandemic vaccine the British drugmaker is developing against the new H1N1 flu virus. Report

Suggested Articles

Intercept presented a data analysis that found treatment with Ocaliva led to "early and consistent improvements" in a range of noninvasive tests.

Intent-driven audiences are inspired to make health-improving changes after a positive online experience. Find out what they’re driven to do.

Days before Amarin faces a pivotal FDA vote on its Vascepa expansion, advisors are set to scrutinize the placebo used in its pivotal outcomes trial.